Bupropion Hydrochloride
- Product NDC
- 70518-2634
- 11-digit product format
- 705182634
- Labeler code
- 70518
- Product ID
- 70518-2634_efccd419-2efc-7a0c-e053-2a95a90ada19
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA210015
- Marketing category
- ANDA
- Marketing start
- 2020-03-18
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2634-0 | 70518263400 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2634-0) | 2020-03-18 | 0000-00-00 | No | No | Current |
| 70518-2634-1 | 70518263401 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2634-1) | 2022-10-16 | 0000-00-00 | No | No | Current |